-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Astrocyte Pharmaceuticals Secures $9.5 Million Series B To Advance Phase 2 Clinical Development Of Breakthrough Tbi And Concussion Therapy Ast-004

Reuters·09/30/2026 10:00:52

Please log in to view news